July 26, 2016 5:00 PM ET

Healthcare Equipment and Supplies

Company Overview of Insulet Corporation

Executive Profile

Daniel J. Levangie B.S.

Executive Vice President and President of Insulet Drug Delivery, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
65$3,704,299
As of Fiscal Year 2015

Background

Mr. Daniel J. Levangie, also known as Dan, B.S., has been an Executive Vice President at Insulet Corporation since March 25, 2016. Mr. Levangie has been President of Insulet Drug Delivery at Insulet Corporation since February 10, 2015. He was a Managing Partner and Principal at Constitution Medical Investors. He has over three decades of industry experience including leadership expertise in the commercial operations and sales and marketing of medical devices and pharmaceuticals. ...

Corporate Headquarters

600 Technology Park Drive
Billerica, Massachusetts 01821

United States

Phone: 978-600-7000
Fax: 978-600-0120

Board Members Memberships

Director
Chairman
Chairman
2010-Present
Independent Director, Member of Nominating & Governance Committee and Member of Audit Committee
2010-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee

Education

BS
Northeastern University

Other Affiliations

Annual Compensation

Salary$400,750
Total Annual Compensation$400,750

Stocks Options

Restricted Stock Awards$200,000
All Other Compensation$6,825
Exercisable Options$34,000
Exercisable Options Value$675,700
Unexercisable Options$253,000
Unexercisable Options Value$1,808,170
Total Value of Options$2,483,870
Total Number of Options$287,000

Total Compensation

Total Annual Cash Compensation$816,516
Total Short Term Compensation$400,750
Other Long Term Compensation$206,825
Total Calculated Compensation$3,704,299
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$400.0K
Eric M. Green Chief Executive Officer, President and Director
West Pharmaceutical Services, Inc.
$1.1M
Andrew Reynolds Smith Chief Executive Officer and Executive Director
Smiths Group plc
--
Simon Michel Chief Executive Officer
Ypsomed Holding AG
$575.6K
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$566.3K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Insulet Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.